We are pleased to invite you to theThird Latin American Bacteriophage Conference – PHAGE OPTION 2024, which will take place from December 4th to 6th, 2024 at the University of Los Andes, Caribbean Campus, in Cartagena, Colombia.
PHAGE OPTION’s vision is to become a leading regional conference for exchanging knowledge and fostering collaboration among researchers, professionals, and students passionate about phage applications in human, animal, and plant health. We envision a platform for open dialogue and active participation among phage researchers, industry leaders, and the medical field alike. Our collective goal is to strengthen regional ties, empower local researchers, and remain at the forefront of global advances in phage research.
Objectives of the conference
1.Underline the impact of antimicrobial resistance in Latin America as a driving factor for the development and implementation of phage technology.
2.Connect local researchers with global experts to advance knowledge about bacteriophages.
3.Provide a comprehensive platform for the dissemination and discussion of advancements in bacteriophage therapy, including new technologies and applications, among researchers and professionals from different fields.
4.Promote knowledge and technology transfer among industry, researchers, and professionals from different disciplines.
Speakers
Influential Voices at the Forefront of Human, Animal, and Plant Health:
Dr. Alexander “Sandro” Sulakvelidze
President and CEO Intralytix, Inc.
Dr. Sofia Corte-Real
CSO and Deputy CEO Technophage
Dr. Martha Vives
Departamento de Ciencias Biológicas, Universidad de los Andes
Juan Camilo Farfán, MSc, PhD cand.
Departamento de Ciencias Biológicas, Universidad de los Andes
Dr. Frenk Smrekar
CEO JAFRAL
Dr. Jessica Sacher
Staff Scientist, Bollyky Lab, Stanford University
Dr. Krystyna Dąbrowska
Phage Molecular Biology Lab, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Dr. Mariana Piuri
Investigadora Independiente de CONICET. Profesora Asociada, Departamento de Química Biológica, FCEN, UBA
Dr. Sandra Morales
Managing director of Phage Consulting Pty Ltd
Dr. Pilar Donado
Investigadora Ph.D. Corporación Colombiana de Investigación Agropecuaria AGROSAVIA
Dr. Alejandro Reyes
Departamento de Ciencias Biológicas, Universidad de los Andes
Dr. Viviana Clavijo
Gerente Sciphage S.A.S.
Dr. Juan Pablo Londoño
Microbiólogo. Médico infectólogo pediatra
Clínica Infantil Colsubsidio
Hospital Universitario Mayor Méderi
Dr. Mikeljon Nikolich
Chief of the Bacteriophage Therapeutics group in the Wound Infections Department
Bacterial Diseases Branch, at the Walter Reed Army Institute of Research (WRAIR)
Dr. Bob Blasdel
Deputy CSO
Vésale Bioscience
Dr. Graham F. Hatfull
University of Pittsburgh
Dr. Judy Natalia Jiménez Quiceno
Universidad de Antioquia
Dr. Gina Suh, MD
Assistant Professor of Medicine
Mayo Clinic, USA
Dr. Mzia Kutateladze
Director of Eliava Institute
President of the Eliava Foundation
Dr. Peter Fineran
University of Otago, New Zealand
Dr. Susan Lehman
Food and Drug Administration
USA
Topics
History and fundamentals of phage therapy.
Technologies and applications of phage therapy.
New Technologies in Phage Therapy: Artificial Intelligence.
Phage therapy for respiratory diseases.
Immunology and microbiota: intertwined with phage therapy.
Production and Applications in Agriculture and Food Safety.
In addition to the captivating scientific program, Cartagena offers a vibrant cultural atmosphere and stunning landscapes, ensuring a memorable experience for all participants. We are committed to providing a welcoming and supportive environment for networking, forging new collaborations, and advancing bacteriophage research in Latin America and beyond.
Register your work in either oral presentation or poster format, and secure your spot at Phage Option 2024! Don't miss the opportunity to stand out and be part of the forefront in bacteriophage research!
To access the special event rate, please contact Olga Patricia Herrera, Commercial Executive.
+57(310) 363 66 94
Email: Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.